* Says suspended further clinical development of Hydros-TA
and that it is actively pursuing a strategic transaction
The post BRIEF-Carbylan Therapeutics says suspended further clinical development of Hydros-TA appeared first on NASDAQ.
BRIEF-Carbylan Therapeutics says suspended further clinical development of Hydros-TA
